Frontiers in fatty liver: recent advances in pathogenic mechanisms, assessment of patients’ prognosis and pharmacotherapy

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

(2023) Zobair M. Younossi et al.   HEPATOLOGY

A multi-society Delphi consensus statement on new fatty liver disease nomenclature

(2023) Mary E. Rinella et al.   JOURNAL OF HEPATOLOGY

Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment

(2023) Paloma Sangro et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD

(2023) Jose M. Herranz et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Antifibrogenic and apoptotic effects of Ocoxin in cultured rat hepatic stellate cells

(2022) Marina Ruiz de Galarreta et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

The serum uric acid/creatinine ratio is associated with nonalcoholic fatty liver disease in the general population

(2022) Silvia Sookoian et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease

(2022) Catalina Atorrasagasti et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers

(2022) Francesca Terracciani et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Molecular and cellular mechanisms underlying the hepatoprotective role of ghrelin against NAFLD progression

(2022) Carlota Tuero et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

From the origin of NASH to the future of metabolic fatty liver disease

(2021) Andreas Geier et al.   GUT

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

(2020) Rod S. Taylor et al.   GASTROENTEROLOGY

NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

(2020) Giovanni Targher et al.   GUT

From NASH to HCC: current concepts and future challenges

(2019) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease

(2019) Fasiha Kanwal et al.   HEPATOLOGY

Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future

(2018) Ana Ruth Araújo et al.   LIVER INTERNATIONAL

Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease

(2009) E. VILAR GOMEZ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS